Remove 2028 Remove FDA Remove Governance
article thumbnail

Connected Medical Devices—the Next Target for Ransomware Attacks

Healthcare IT Today

Food and Drug Administration (FDA) has recognized the problem and issued multiple guidance documents over the years—as recently as this March —to ensure the cybersecurity of medical devices. Although none of the FDA recommendations are legally enforceable, device manufacturers no longer have a choice but to comply.

article thumbnail

How Policy Changes Can Fix Market Distortions in Healthcare and Improve the Country’s Debt

Healthcare IT Today

A major justification for President Biden’s tax hike proposal is to shore up the tenuous finances of Medicare whose trust fund is forecasted to be depleted by 2028. Historically, it is the most prolific driver of family bankruptcy, and now it is on its way to bankrupting our country collectively.

Nurses 78
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Step-by-step guide to Medical Device Quality System Management

Dot Compliance

Government regulators have been doing their best to ensure that patients receive the safest and most efficient device possible. The two most relevant quality regulations for medical device manufacturers are the FDA 21 CFR Part 820 and the ISO 13485:2016. What are the main regulations governing medical device QMS?

FDA 52
article thumbnail

5 Necessary Steps for Building a Risk Assessment Framework

Dot Compliance

between 2021, and 2028. Common risk areas often include (but aren’t limited to): Cybersecurity Audit management Government pricing General data protection regulation. FDA’s Safer Technologies Program (SteP) for Medical Devices. The life science sector is one of the country’s most lucrative industries.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

Having analyzed over 2000 responses received, the government will now take forward legislation to reform of the UK clinical trials regulatory framework that will: Ensure patients and their safety are at the focus of all clinical trials and bring the benefits of clinical trials to everyone.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

The sponsor is also responsible for implementing a Quality Assurance system to ensure that the clinical trial is conducted and data generated, documented, and reported in compliance with the protocol and Good Clinical Practice (GCP) guidelines issued by the CDSCO Directorate General of Health Services Government of India.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

Of interest is a reference to the FDA’s draft document “Computer Software Assurance for Production and Quality System Software,” which was recently published on 13 September 2022. PCPC looks forward to working with the FDA and key stakeholders to implement this important legislation.